Literature DB >> 7971716

Effect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitro.

P Y Yeh1, P L Smith, H Ellens.   

Abstract

Medium chain glycerides (MCGs) have been reported to enhance intestinal absorption of hydrophilic drugs. However, the mechanisms involved in absorption enhancement are not well understood. The effects of MCGs (CapMul MCM) on physiological properties of rabbit ileum and distal colon, including active ion transport, transepithelial resistance (Rt) and passive permeability, have been investigated in vitro. CapMul MCM inhibited active ion transport (measured as a decrease in short-circuit current, Isc) in both intestinal segments in a concentration-dependent manner. The inhibition of Isc was rapidly reversible (within 100 min) upon removal of CapMul MCM. The data indicate that CapMul MCM preferentially affected ion transport by villus cells in the ileum and surface cells in the distal colon. Ion transport in crypt cells in both segments was not significantly altered. Rt of the ileum was not significantly affected by 5% CapMul MCM, while mannitol transport was 6 fold enhanced. Treatment of distal colon with 1% CapMul MCM reduced Rt by 95%, while mannitol transport was 100 fold enhanced. In a parallel experiment, mucosal(m)-to-serosal(s) transport of cephalexin, a beta-lactam antibiotic, in the ileum was about 40% reduced in the presence of 5% CapMul MCM, whereas transport in the s-to-m direction was 2.5 fold enhanced. Treatment of the distal colon with 1% CapMul MCM resulted in 25 fold enhancement of cephalexin transport in either direction. These results suggest that absorption enhancement by MCGs results from an increased permeability of the intestine confined to the villus or surface epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971716     DOI: 10.1023/a:1018988832492

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Ion transport by rabbit colon. I. Active and passive components.

Authors:  R A Frizzell; M J Koch; S G Schultz
Journal:  J Membr Biol       Date:  1976       Impact factor: 1.843

Review 2.  Intestinal drug absorption enhancement: an overview.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

3.  Enhancement of membrane permeability to a poorly absorbed drug by medium-chain glycerides: effect of medium-chain glycerides on the release of phenol red from egg phosphatidylcholine liposomes.

Authors:  K Higaki; N Takechi; M Hashida; H Sezaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-03       Impact factor: 1.645

4.  Effect of medium-chain glycerides on the intestinal absorption of phenol red: studies on mechanisms of the promoting effect.

Authors:  K Higaki; N Takechi; M Kato; M Hashida; H Sezaki
Journal:  J Pharm Sci       Date:  1990-04       Impact factor: 3.534

5.  In vitro nasal transport across ovine mucosa: effects of ammonium glycyrrhizinate on electrical properties and permeability of growth hormone releasing peptide, mannitol, and lucifer yellow.

Authors:  P M Reardon; C H Gochoco; K L Audus; G Wilson; P L Smith
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

6.  Lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro.

Authors:  P M Reardon; D A Wall; T K Hart; P L Smith; C H Gochoco
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

7.  Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs.

Authors:  M Sekine; H Terashima; K Sasahara; K Nishimura; R Okada; S Awazu
Journal:  J Pharmacobiodyn       Date:  1985-04

8.  Rate-controlled absorption enhancement of rectally administered cefazolin in rats by a glyceride mixture (MGK).

Authors:  E J van Hoogdalem; A M Stijnen; A G de Boer; D D Breimer
Journal:  J Pharm Pharmacol       Date:  1988-05       Impact factor: 3.765

9.  Enhancement of jejunal and colonic absorption of fosfomycin by promoters in the rat.

Authors:  T Ishizawa; M Hayashi; S Awazu
Journal:  J Pharm Pharmacol       Date:  1987-11       Impact factor: 3.765

10.  Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers.

Authors:  G Beskid; J Unowsky; C R Behl; J Siebelist; J L Tossounian; C M McGarry; N H Shah; R Cleeland
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

View more
  6 in total

1.  Simulated reflux decreases vocal fold epithelial barrier resistance.

Authors:  Elizabeth Erickson; Mahalakshmi Sivasankar
Journal:  Laryngoscope       Date:  2010-08       Impact factor: 3.325

Review 2.  Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.

Authors:  P P Constantinides
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

3.  Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.

Authors:  Jaclyn M Hosmer; Alexandre A Steiner; Luciana B Lopes
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

4.  Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.

Authors:  Jianping Qi; Jie Zhuang; Wei Wu; Yi Lu; Yunmei Song; Zhetao Zhang; Jia Jia; Qineng Ping
Journal:  Int J Nanomedicine       Date:  2011-05-10

5.  In Vitro Evaluation of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) Containing Room Temperature Ionic Liquids (RTILs) for the Oral Delivery of Amphotericin B.

Authors:  Eleni Kontogiannidou; Thomas Meikopoulos; Helen Gika; Emmanuel Panteris; Ioannis S Vizirianakis; Anette Müllertz; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2020-07-25       Impact factor: 6.321

6.  Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Qing Lv; Xin-Jiang Tang; Li-Ming Li; Qing-Xia Fang; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2012-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.